Citations

Mayo Clinic

Showing 10 of 108551 citations.

Unplanned returns to the operating room: a quality improvement methodology for the comparison of institutional outcomes to national benchmarks
Mikula, Anthony L. , Kerezoudis, Panagiotis , Biedermann, Aaron, Bydon, Mohamad , Biedermann, Aaron J, Michalopoulos, Giorgos D. , Parney, Ian F. , Gompel, Jamie J. Van

Journal of Neurosurgery | April 13, 2024 | Volume: 141 | Issue: 3 | Pages: 804-814

10.3171/2024.1.jns221492 | PMID 38608305 Get It

OBJECTIVE Unplanned returns to the operating room (RORs) constitute an important quality metric in surgical practice. In this study, the authors present a methodology to compare a department’s unplanned ROR rates with national benchmarks in the context of large-scale quality of care surveillance. METHODS The authors identified unplanned RORs within 30 days from the initial surgery at their institution during the period 2014–2018 using an institutional documentation platform that facilitates the collection of reoperation information by providers in the clinical setting. They divided the procedures into 28 groups by Current Procedural Terminology and International Classification of Diseases, 9th and 10th Revision codes. They estimated national benchmarks of unplanned RORs for these procedure groups via querying the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) registry during the period 2014–2018. Finally, they numerically assessed the unplanned ROR rates at their institution compared with those calculated from the ACS NSQIP registry. RESULTS Using the above methodology, the authors were able to classify 12,575 of the cases performed in their department during the period of interest, including 6037 (48%) cranial cases and 6538 (52%) spinal or peripheral nerve cases. Among those, 161 (1.3%) presented with complications that required an unplanned ROR within 30 days from the initial surgery. The respective cumulative unplanned ROR rate in the ACS NSQIP registry during the same timeframe was 3.6%. Among 15 categories of cranial procedures, the cumulative unplanned ROR rate was 1.3% in the authors’ department and 5.6% in the ACS NSQIP registry. Among 13 categories of spinal and peripheral nerve procedures, the cumulative unplanned ROR rate was 1.3% in the authors’ department and 2.8% in the ACS NSQIP registry. Unplanned ROR rates at the authors’ institution were lower than the national average for each of the 28 procedure groups of interest. Yearly analysis of institutional ROR rates for the five most commonly performed procedures showed lower reoperation rates compared with the national benchmarks. CONCLUSIONS Using an institutional documentation tool and a widely available national database, the authors developed a reproducible and standardized method of comparing their department’s outcomes with national benchmarks per procedure subgroup. This methodology accommodates longitudinal quality surveillance across the different subspecialties in a neurosurgical department and may illuminate potential shortcomings of care delivery in the future.
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
Friedman, Joshua, Yabe, Mariko , Petrova‐Drus, Kseniya , Pulitzer, Melissa , Busam, Klaus J. , Rampal, Raajit K. , Ulaner, Gary A. , Reddy, Ryan , Yeh, Randy , Rotemberg, Veronica , Hershkovitz‐Rokah, Oshrat , Shpilberg, Ofer , Abeykoon, Jithma P. , Fidai, Shiraz , Gannamani, Vedavyas, Zia, Maryam, Panageas, Katherine S. , Rosenblum, Marc K. , Durham, Benjamin H. , Reiner, Anne S , Mazor, Roei D , Hershkovitz-Rokah, Oshrat , Goyal, Guarav , Abeykoon, Jithma P , Diamond, Eli L , Ulaner, Gary , Reiner, Anne S. , Doǧan, Ahmet , Francis, Jasmine H. , Hatzoglou, Vaios , Lacouture, Mario E. , Mazor, Roei David , Goyal, Gaurav , Go, Ronald S. , Rech, Karen L. , Morlote, Diana M. , Abdel‐Wahab, Omar , Diamond, Eli L.

British Journal of Haematology | April 13, 2024 | Volume: 205 | Issue: 1 | Pages: 127-137

10.1111/bjh.19462 | PMID 38613141 Get It

Summary Histiocytic neoplasms are diverse clonal haematopoietic disorders, and clinical disease is mediated by tumorous infiltration as well as uncontrolled systemic inflammation. Individual subtypes include Langerhans cell histiocytosis (LCH), Rosai–Dorfman–Destombes disease (RDD) and Erdheim–Chester disease (ECD), and these have been characterized with respect to clinical phenotypes, driver mutations and treatment paradigms. Less is known about patients with mixed histiocytic neoplasms (MXH), that is two or more coexisting disorders. This international collaboration examined patients with biopsy‐proven MXH with respect to component disease subtypes, oncogenic driver mutations and responses to conventional (chemotherapeutic or immunosuppressive) versus targeted (BRAF or MEK inhibitor) therapies. Twenty‐seven patients were studied with ECD/LCH (19/27), ECD/RDD (6/27), RDD/LCH (1/27) and ECD/RDD/LCH (1/27). Mutations previously undescribed in MXH were identified, including KRAS, MAP2K2, MAPK3, non‐V600‐BRAF, RAF1 and a BICD2‐BRAF fusion. A repeated‐measure generalized estimating equation demonstrated that targeted treatment was statistically significantly (1) more likely to result in a complete response (CR), partial response (PR) or stable disease (SD) (odds ratio [OR]: 17.34, 95% CI: 2.19–137.00, p = 0.007), and (2) less likely to result in progression (OR: 0.08, 95% CI: 0.03–0.23, p < 0.0001). Histiocytic neoplasms represent an entity with underappreciated clinical and molecular diversity, poor responsiveness to conventional therapy and exquisite sensitivity to targeted therapy.
Relationship between number of prior lumbar spine surgeries and outcomes following spinal cord stimulator implantation: A multisite, retrospective pooled analysis
Hagedorn, Jonathan M. , D’Souza, Ryan S. , Yadav, Abhishek , George, Tony K., DeTemple, Nathan, Ovrom, Erik A. , Lam, Christopher , Sayed, Dawood , Hall, Morgan , Stephenson, Lauren , Rivera, Zach, Hoelzer, Bryan C. , Ovrom, Erik, Lam, Christopher M , Deer, Tim , Hagedorn, Jonathan M , D'Souza, Ryan S , Stephenson, Lauren, Deer, Timothy R.

Pain Practice | April 13, 2024 | Volume: 24 | Issue: 7 | Pages: 882-890

10.1111/papr.13371 | PMID 38613136 Get It

Abstract Objectives Lumbar spine surgery is a common procedure for treating disabling spine‐related pain. In recent decades, both the number and cost of spine surgeries have increased despite technological advances and modification in surgical technique. For those patients that have continued uncontrolled back and/or lower extremity pain following lumbar spine surgery, spinal cord stimulation (SCS) has emerged as a viable treatment option. However, the impact of lumbar spine surgical history remains largely unstudied. Specifically, the current study considers the impact of number of prior lumbar spine surgeries on pain relief outcomes following SCS implantation. Materials and Methods We queried the electronic medical record of five separate pain practices for all patients who have undergone a SCS implant between January 1, 2017, and March 1, 2020. Inclusion criteria consisted of any patients with an SCS implant who underwent a prior lumbar spine surgery. The primary outcome was the mean calculated percentage pain relief in patients based on number of prior lumbar spine surgeries. Results There was a total of 1974 total SCS implant cases identified across five separate pain clinics. There was no difference in mean calculated pain relief in patients with one prior spine surgery versus those with two or more prior spine surgeries (28.2% vs. 25.8%, adjusted β‐coefficient –3.1, 95% CI –8.9 to 2.7, p = 0.290). Similarly, when analyzing number of spine surgeries as a continuous variable, there was no association between number of spine surgeries and calculated pain relief (adjusted β‐coefficient –1.5, 95% CI –4.0 to 1.1, p = 0.257). Additionally, after patients were stratified based on waveform, there was no association between number of prior lumbar spine surgeries (analyzed both as a categorical and continuous variable) and calculated percentage pain relief. Conclusions This multicentered retrospective study found that there was no significant difference in pain scores in individuals who received SCS following one or more lumbar spine surgeries. Additionally, the waveform of the SCS device had no statistically significant impact on post‐operative pain scores following one or more lumbar spine surgeries.
Patient Interest in Quadriceps Autograft Anterior Cruciate Ligament Reconstruction Is Increasing Over Other Autograft Options: A 12‐Year Google Trends Analysis
Brinkman, Joseph C. , Lai, Cara , Pollock, Jordan R. , McQuivey, Kade S. , Thompson, Adam B. , Chhabra, Anikar , Pollock, Jordan Riley , Chhabra, Anikar , Tummala, Sailesh V , Moore, M. Lane , Tummala, Sailesh V. , Hassebrock, Jeffrey D.

Arthroscopy, Sports Medicine, and Rehabilitation | April 12, 2024 | Volume: 6 | Issue: 3 | Pages: No page available

10.1016/j.asmr.2024.100942 | PMID 39006776 Get It

Purpose To use Google trends to explore differences in public interest among types of anterior cruciate ligament (ACL) autografts, specifically quadriceps tendon, patellar tendon, and hamstring tendon autografts, between 2008 and 2019. Methods Data were obtained by querying Google Trends for key terms and phrases for online search data ranging from January 2008 to December 2019. Relative search volumes were created based on searches related to ACL reconstruction with comparative analysis generated for search terms related to quadriceps ACL, patellar tendon ACL, and hamstring ACL autografts. Statistical analysis included linear regression analysis, comparison of quarterly search volume trends over time, and comparison of cumulative annual search volumes for 2008 versus 2019. Results Linear models for respective search terms were statistically significant for the quadriceps ( P < .001) and patellar ( P = .007) tendon autograft groups but not the hamstring group ( P = .129). The quadriceps autograft group demonstrated a 12‐year search volume trend change of 0.56, which was significantly greater than the hamstring (0.07; P < .001) and patellar tendon (0.168; P < .001) groups. There was no significant difference in the trend change between hamstring and patellar tendon groups ( P = .20). Percent change in cumulative relative annual search volumes between 2008 and 2019 was 112% for the quadriceps tendon group, 12.9% for the hamstring group, and 18.6% for the patellar tendon group. Conclusions This study indicates a consistently increasing public interest in quadriceps tendon autograft for ACL reconstruction. The quadriceps autograft group demonstrated a significantly greater 12‐year online search volume, greater linear correlation, and larger percent change between 2008 and 2019 compared with patellar tendon or hamstring autograft groups. Clinical Relevance Awareness of patient perceptions has value in informing shared decision‐making, aligning patient expectations, and guiding areas of future research. Each of these has an impact on patient care. Being aware of patient interest and expectations is particularly important in areas with controversial or emerging research.
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study
Buch, Maya H , Bhatt, Deepak L. , Charles‐Schoeman, Christina , Giles, Jon T. , Koch, Gary G., Ytterberg, Steven R. , Nagy, Edward, Jo, Hyejin, Connell, Carol A., Masri, Karim R. , Yndestad, Arne, Ytterberg, Steven, Masri, Karim Richard , Bhatt, Deepak L , Giles, Jon T , Mikuls, Ted R. , Kwok, Kenneth

RMD Open | April 12, 2024 | Volume: 10 | Issue: 2 | Pages: e003912

10.1136/rmdopen-2023-003912 | PMID 38609322 Get It

Objectives Compare the risk of extended major adverse cardiovascular (CV) event (MACE) composite outcomes and component events in patients with rheumatoid arthritis (RA) treated with tofacitinib versus tumour necrosis factor inhibitors (TNFi) in Oral Rheumatoid Arthritis Trial (ORAL) Surveillance. Methods Patients with RA aged ≥50 years and with ≥1 additional CV risk factor received tofacitinib 5 mg or 10 mg two times per day or TNFi. MACE (non-fatal myocardial infarction (MI), non-fatal stroke or CV death (MACE-3)) was extended by sequential addition of CV events (hospitalisation for unstable angina (MACE-4), coronary revascularisation (MACE-5), transient ischaemic attack (MACE-6), peripheral vascular disease (MACE-7)), heart failure (HF) hospitalisation (MACE-8) and venous thromboembolism (VTE; (MACE-8 plus VTE)). HRs (tofacitinib vs TNFi) were evaluated for MACE and individual components. Results HRs for MACE-4 to MACE-8 with combined and individual tofacitinib doses versus TNFi were similar. Risk of MACE-8 plus VTE appeared similar with tofacitinib 5 mg two times per day versus TNFi (HR 1.12 (0.82 to 1.52)), but higher with tofacitinib 10 mg two times per day versus TNFi (HR 1.38 (1.02 to 1.85)). Risk of MI was higher with tofacitinib versus TNFi, but difference in risk of other individual CV events was not suggested. Across extended MACE definitions, risk appeared higher with tofacitinib versus TNFi in those with atherosclerotic CV disease or age ≥65 years. Conclusion In ORAL Surveillance, risk of composite CV endpoints combining all ischaemic CV events and HF did not appear different with tofacitinib versus TNFi. The totality of CV risk was higher with tofacitinib 10 mg two times per day versus TNFi, driven by an increase in VTE. Trial registration number NCT02092467.
Machine Learning–Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma
Jørgensen, Rasmus Rask Kragh , Bergström, Fanny , Eloranta, Sandra , Severinsen, Marianne Tang , Smeland, Knut B. , Fosså, Alexander , Christensen, Jacob Haaber , Hutchings, Martin , Dahl‐Sørensen, Rasmus Bo , Kamper, Peter , Glimelius, Ingrid , Smedby, Karin E. , Parsons, Susan K. , Rodday, Angie Mae , Evens, Andrew M. , Rask Kragh Jørgensen, Rasmus , Bjøro Smeland, Knut , E Smedby, Karin , K Parsons, Susan , Maurer, Matthew , Evens, Andrew M , Fosså, Alexander , Maurer, Matthew J. , El‐Galaly, Tarec Christoffer , Jakobsen, Lasse Hjort

JCO Clinical Cancer Informatics | April 12, 2024 | Volume: No volume available | Issue: 8 | Pages: No page available

10.1200/cci.23.00255 | PMID 38608215 Get It

PURPOSE Patients diagnosed with advanced-stage Hodgkin lymphoma (aHL) have historically been risk-stratified using the International Prognostic Score (IPS). This study investigated if a machine learning (ML) approach could outperform existing models when it comes to predicting overall survival (OS) and progression-free survival (PFS). PATIENTS AND METHODS This study used patient data from the Danish National Lymphoma Register for model development (development cohort). The ML model was developed using stacking, which combines several predictive survival models (Cox proportional hazard, flexible parametric model, IPS, principal component, penalized regression) into a single model, and was compared with two versions of IPS (IPS-3 and IPS-7) and the newly developed aHL international prognostic index (A-HIPI). Internal model validation was performed using nested cross-validation, and external validation was performed using patient data from the Swedish Lymphoma Register and Cancer Registry of Norway (validation cohort). RESULTS In total, 707 and 760 patients with aHL were included in the development and validation cohorts, respectively. Examining model performance for OS in the development cohort, the concordance index (C-index) for the ML model, IPS-7, IPS-3, and A-HIPI was found to be 0.789, 0.608, 0.650, and 0.768, respectively. The corresponding estimates in the validation cohort were 0.749, 0.700, 0.663, and 0.741. For PFS, the ML model achieved the highest C-index in both cohorts (0.665 in the development cohort and 0.691 in the validation cohort). The time-varying AUCs for both the ML model and the A-HIPI were consistently higher in both cohorts compared with the IPS models within the first 5 years after diagnosis. CONCLUSION The new prognostic model for aHL on the basis of ML techniques demonstrated a substantial improvement compared with the IPS models, but yielded a limited improvement in predictive performance compared with the A-HIPI.
A Wireless Battery-Free Implant With Optical Telemetry for In Vivo Cortical Stimulation
Benbuk, Ahmed Abed , Moniz‐Garcia, Diogo , Quiñones‐Hinojosa, Alfredo , Christen, Jennifer Blain , Benbuk, Abed , Gulick, Daniel , Quinones-Hinojosa, Alfredo , Blain Christen, Jennifer , Garcia, Diogo Moniz , Gulick, Daniel

IEEE Sensors Letters | April 12, 2024 | Volume: 8 | Issue: 5 | Pages: 1-4

10.1109/lsens.2024.3387370 | PMID 38818033 Get It

A Radiological Clip Design Using Ultrasound Identification to Improve Localization
Cario, Jenna , Kou, Zhengchang , Miller, Rita J. , Dickenson, April , Lee, Christine U. , Oelze, Michael L.

IEEE Transactions on Biomedical Engineering | April 12, 2024 | Volume: 71 | Issue: 9 | Pages: 2699-2707

10.1109/tbme.2024.3388203 | PMID 38607722 Get It

AI As the New Age Estimator: Pioneering Customized Facial Surgery Outcomes
Alameddine, Khaled O. , Rames, Jess D. , Bakri, Karim , Mardini, Samir

Aesthetic Surgery Journal Open Forum | April 12, 2024 | Volume: 6 | Issue: Supplement_1 | Pages: No page available

10.1093/asjof/ojae007.087 Get It

Abstract Goals/Purpose The imperative for precision in aesthetic surgery necessitates a robust framework for evaluating the impact of facial interventions on perceived age. Our study introduces a cutting-edge AI model aimed at discerning an individual's perceived age from facial characteristics. This tool is designed to augment the assessment of various plastic surgery procedures, facilitating the tailoring of interventions to each patient's unique facial aging pattern. Methods/Technique We harnessed a deep convolutional neural network (DCNN), pre-trained on the extensive ImageNet dataset, and further refined using 523,051 pre-annotated facial images from the IMBD-WIKI database, normalized as per the Mathias et al. face detection paradigm. Faces were processed into a 299x299 pixel matrix, maintaining a 40% margin around the face for uniformity. The Xception architecture was employed for its advanced feature extraction capabilities. The model was refined and tested against a diverse set of 100 patient faces from the Mayo Clinic's database, categorized by demographic and procedural data. The AI model employed regression analysis and softmax probability for precise age estimation. Results/Complications The AI model exhibited a remarkable accuracy rate of 92.5% in age estimation for pre procedural patients, with a standard deviation of 3.2 years. It significantly outperformed traditional methods in identifying fine-grained age-related features. The AI model discerned an average perceived age reduction of 3.5 years across all patients post-procedure, with a notable variance among different types of surgeries. Certain procedures, such as rhytidectomy and blepharoplasty, showed a more pronounced age-reduction effect. Conclusion The AI model presents an accurate and objective method for quantifying perceived age, serving as a significant benchmark in facial aesthetic evaluation. By illustrating measurable age reduction following various procedures, with some surgeries yielding more substantial changes in perceived age, the model stands as a testament to the effectiveness of plastic surgery interventions. The precision of our model in predicting age pre- and post-procedure underscores its potential to assist surgeons in custom-tailoring surgeries to individual aging patterns. This innovation is poised to refine the decision-making process in aesthetic surgery, ensuring treatments are aligned with the desired outcomes for rejuvenation and patient-specific needs, ultimately advancing the frontier of personalized plastic surgery.
Preoperative Vaginal Microbiome as a Predictor of Postoperative Urinary Tract Infection
Occhino, John A. , Byrnes, Jenifer N., Wu, Pei‐Ying , Walther-Antonio, Marina R

No container title available | April 12, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4069233/v1 | PMID 38659758 Get It

Abstract This is a single Institute, prospective cohort study. We collected twenty- two postmenopausal women with pelvic organ prolapse planning to undergo vaginal hysterectomy with transvaginal pelvic reconstructive surgery, with or without a concomitant anti-incontinence procedure. Vaginal swabs and urine samples were longitudinally collected at five time points: preoperative consult visit (T1), day of surgery prior to surgical scrub (T2), immediately postoperative (T3), day of hospital discharge (T4), and at the postoperative exam visit (T5). Women experiencing urinary tract infection symptoms provided a sample set prior to antibiotic administration (T6). Microbiome analysis on vaginal and urinary specimens at each time point. Region V3-V5 of the 16S ribosomal RNA gene was amplified and sequenced. Sample DNA was analyzed with visit T1, T2, T5 and T6. Six (27.3%) participants developed postoperative urinary tract infection whose vaginal sample at first clinical visit (T1) revealed beta-diversity analysis with significant differences in microbiome structure and composition. Women diagnosed with a postoperative urinary tract infection had a vaginal microbiome characterized by low abundance of Lactobacillus and high prevalence of Prevotella and Gardnerella species. In our cohort, preoperative vaginal swabs can predict who will develop a urinary tract infection following transvaginal surgery for pelvic organ prolapse.